This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Aberizk W, Silver B, Henderson IC (1986) The use of radiotherapy for treatment of isolated local-regional recurrence of breast cancer after mastectomy, Cancer 58:1214
Abner A, Recht A, Eberlein T et al. (1993) Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early stage breast cancer, J Clin Oncol 11:44
Buchholz TA, Austin-Semour MM, Moe RE (1993) Effect of delay in radiation in the combined modality treatment of breast cancer, Int J Radiat Oncol Biol Phys 26:23–35
Buzzoni R, Bonadonna G, Valagussa P et al. (1991) Adjuvant chemotherapy with doxorubicin plus cyclophosphamid, methotrexate and fluorouracil in the treatment of resectable breast cancer with more than three axillary nodes, J Clin Oncol 9:2134
Chen K, Montague E, Oswald M (1986) Results of irradiation in the treatment of loco-regional breast cancer recurrence, Cancer 56:1269–1273
Clarke D, Martinez A (1992) Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: a review article for surgeons, pathologists and radiation and medical oncologists, J Clin Oncol 10:474
Cuzick J, Steward H, Peto R et al. (1994) Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer, Cancer Treat Rep 71:15
Cuzick J, Steward H, Rutquist L et al. (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy, J Clin Oncol 12:447–453
Di Saia PJ, Creasman WT (1997) Breast diseases. In: Di Saia PJ, Creasman WT (eds) Clinical gynecologic oncology, 5th edn, Mosby, St. Louis
Dimitrov N, Anderson S, Fisher B et al. (1994) Dose intensification and increased total dose of adjuvant chemotherapy for breast cancer (BC): findings from NSABP B22, Proc ASCO 13:64
Early Breast Cancer Trialist Collaborative Group (EBCTCG) (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomized trials involving 31.000 recurrences and 24.000 deaths among 75.000 women, Lancet 339:1–15 and 71–85
Eiermann W, Engel J (1995) Tumoradaptierte Brustkrebschirurgie. In: Sauer H (Hrsg) Mammakarzinom, Ergebnisse von Diagnostik, Therapie und Nachsorge 3, Zuckschwerdt-Verlag, München
Fentiman IS, Georgy WM, Richards MA (1994) Effect of menstrual phase on surgical treatment of breast cancer, Lancet 344:402
Fisher B, Anderson S, Fisher E et al. (1991) The significance of local recurrence following lumpectomy, Lancet 338:327
Fisher B, Redmond C (1992) Lumpectomy for breast cancer: an update of NSABP experience, J Natl Cancer Inst Monogr 11:7
Fisher B, Constantino J, Redmond C et al. (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen-receptor-positive tumors, N Engl J Med 320:479
Fisher B, Redmond C, Legault-Poisson S et al. (1990) Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the NSABP B16, J Clin Oncol 8:1005
Fisher B, Wolmark N, Bauer M et al. (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet 152:765
Fisher B, Slack NH, Cavanaugh PJ et al. (1970) Postoperative radiotherapy in the treatment of breast cancer: results of the National Surgical Adjuvant Breast Project Clinical Trial, Ann Surg 172:711–732
Fornander T, Cedermark B, Mattsson A et al. (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers, Lancet 1:117
Fowble BL, Solin LJ, Schultz D et al. (1991) Ten year results of conservative surgery and irradiation for Stage I and II breast cancer, Int J Radiat Oncol Biol Phys 21:269–277
Gage I, Recht A, Gelman R et al. (1995) Long term outcome following breast conserving surgery and radiation therapy, Int J Radiat Oncol Biol Phys 33:245–251
Halverson KJ, Taylor ME, Perez CA et al. (1993) Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer, Int J Radiat Oncol Biol Phys 26:593–599
Jänicke F (1995) Adjuvante Hormon- und Chemotherapie des Mammakarzinoms. In: Sauer H (Hrsg) Mammakarzinom. Ergebnisse der Diagnostik, Therapie und Nachsorge 3, Zuckschwerdt-Verlag, München
Kematsu M, Bornstein B, Recht A et al. (1993) Long term results of postoperative radiation therapy following mastectomy with and without chemotherapy in stage I–III breast cancer, Int J Radiat Oncol Biol Phys 25:765
Kreienberg R, Möbius V (1996) Adjuvante Chemotherapie des nodal negativen Mammakarzinoms, Gynäkologe 29:233–241
Kreienberg R, Schneider V (1996) Carcinoma of the breast. In: Sevin BU, Knapstein PG, Köchli OR (eds) Multimodality therapy in gynecologic oncology, Thieme-Verlag, Stuttgart New York
Kurtz JM (1989) Local recurrence after breast conserving surgery and radiotherapy: frequency, time course and prognosis, Cancer 63:1912–1917
Lichter AS, Lippman ME, Danforth DN et al. (1992) Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial of the National Cancer Institute, J Clin Oncol 10:976–983
Lindner H (1995) Kontroverses zur Radiotherapie bei der brusterhaltenden Behandlung des Mammakarzinoms. In: Sauer H (Hrsg) Mammakarzinom. Ergebnisse der Diagnostik, Therapie und Nachsorge 3, Zuckschwerdt-Verlag, München, S. 27–37
Love RR, Cameron L, Connell BL et al. (1991) Symptoms associated with tamoxifen treatment in postmenopausal women, Arch Intern Med 151:1842
Ludwig Breast Cancer Study Group (1989) Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer, N Engl J Med 320:491
McGuire WL, Clark GM (1992) Prognostic factors and treatment decisions in axillary node-negative breast cancer, N Engl J Med 326:1756
Marchant DJ (1997) Invasive breast cancer: Surgical treatment alternatives. In: Marchant DJ (ed) Breast disease, Saunders, Philadelphia
Osborne CK, Clark GM, Ravdin PM (1996) Adjuvant systemic therapy of primary breast cancer. In: Harris JR, Lippman ME, Morrow M, Heilman S (eds). Diseases of the breast, Lippincott-Raven, Philadelphia
Recht A, Come SE, Harris JR (1992) Integration of conservative surgery, radiotherapy and chemotherapy for patients with early-stage breast cancer, Semin Radiat Oncol 2:107–115
Recht H, Houlinan MJ (1995) Axillary lymph nodes and breast cancer, Cancer 76:1491–1512
Rivkin SE, Green S, Metch B et al. (1994) Adjuvant CMFVP versus tamoxifen versus CMFVP and tamoxifen for postmenopausal, node positive and estrogen receptor positive breast cancer patients: a Southwest Oncology Group Study, J Clin Oncol 12:2078
Rutquist L, Petterson D, Johannsen M (1993) Adjuvant radiation therapy versus surgery alone in operable breast cancer: long term follow up in a randomized clinical trial, Radiat Oncol 26:104
Rutquist L, Cedermark B, Glas U et al. (1989) Radiotherapy, chemotherapy and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials, Int J Radiat Oncol Biol Phys 16:629–633
Sarrazin D, Le MG, Arriagada R et al. (1989) Ten year results of a randomized trial comparing a conservative treatment ot mastectomy in early breast cancer, Rad Oncol 14:177–184
Schmidt-Mathiesen H, Bastert G (1993) Mammakarzinom. In: Schmidt-Mathiesen H, Bastert G (Hrsg) Gynäkologische Onkologie, 4. Aufl., Schattauer-Verlag, Stuttgart New York
Schnürch HG (1991) Medikamentöse Therapie bei Mammakarzinomerkrankungen. In: Bender HG (Hrsg) Gynäkologische Onkologie, Thieme-Verlag, Stuttgart New York, S. 377–423
Scottish Cancer Trials Breast Group and ICFR Breast Unit, Guy’s Hospital (1993) Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: The Scottish Trial, Lancet 341:1293
Snacks NPM, Baum M (1993) Primary management of carcinoma of the breast, Lancet 342:1402–1408
Valagussa P, Bonadonna G, Veronesi U (1978) Pattern of relapse and survival following radical mastectomy: analysis of 716 consecutive patients, Cancer 41:1170–1179
Veronesi U, Luini A, Galimberti V et al (1994) Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute Trials, World J Surg 18:70
Wazer DE (1997) Radiation therapy in the management of early invasive breast cancer. In: Marchand DJ (ed) Breast disease, WB Saunders, Philadelphia
Weyland C (1996) Aktuelle Aspekte der Therapie des Mammakarzinoms. Symposiumsbericht, 22. Deutscher Krebskongreß, Berlin, Februar 1996. Gyn Spektrum 2:7–9
Wood WC, Budman DR, Korzun AH et al. (1994) Dose and dose intensity of adjuvant chemotherapy for stage II, node positive breast cancer, N Engl J Med 300:1253
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pietschmann, D., Pietschmann, V. (1998). Therapierichtlinien beim Mammakarzinom. In: Lexikon der Mammadiagnostik. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72101-4_48
Download citation
DOI: https://doi.org/10.1007/978-3-642-72101-4_48
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-63969-5
Online ISBN: 978-3-642-72101-4
eBook Packages: Springer Book Archive